If you’re a regular user of Ramipril, the blood pressure medication, your bottle of pills may be recalled due to a slip-up on the FDA’s front. 600,000 bottles of the commonly used medication are being pulled from shelves because of ingredients used by an unregulated manufacturer, leading to a fear of possible contamination. It’s Ramipril capsules in strengths of 2.5 mg, 5 mg, and 10 mg.
This particular medication is prescribed for hypertension and is used to open the blood vessels and reduce heart pressure, typically administered after a heart attack. One of the ingredients was sourced from a factory in India with improper checks on their suppliers. Although the FDA believes the risk is low, it’s better to be safe than sorry. There have been no reported adverse effects so far, but it’s recommended to dispose of any listed bottles to avoid potential risks.
Check your blood pressure medication for a recalled one made by the Indian company Lupin Pharmaceuticals, which are sold in strengths of 2.5 mg, 5 mg, and 10 mg. The affected bottles have a sell-by date up to July 2026 and are sold in quantities of 90, 10, and 150.
